Skip to main content
Equibles

Brevan Howard Capital Management LP

Position in BSX — Boston Scientific Corp

CIK 1512857 ST. HELIER, Y9
Back to BSX Full portfolio

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,939,925
-$7,825,966 QoQ
Shares Held
68,883
-59.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#502
of 1,477 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $46,922,231 across 36 Medical Devices names. BSX ranks #6 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 STE
STERIS plc
 20,654 $4,349,112
2 BIO
Bio-Rad Laboratories, Inc.
 13,718 $4,027,741
3 UFPT
Ufp Technologies Inc
 13,400 $3,552,742
4 EW
Edwards Lifesciences Corp
 34,889 $3,156,058
5 TXG
10x Genomics, Inc.
 77,803 $2,982,967
6 BSX
Boston Scientific Corp
This page 		68,883 $2,939,925
7 SYK
Stryker Corp
 9,013 $2,837,652
8 IRTC
iRhythm Holdings, Inc.
 23,847 $2,836,600

All Filings in BSX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,939,925 68,883
2026-03-31 $10,765,891 171,568
2025-12-31 $19,142,084 200,756
2025-09-30 $7,209,389 73,844
2025-06-30 $8,367,131 77,899
2025-03-31 $8,889,444 88,119
2024-12-31 $8,694,408 97,340
2024-09-30 $2,752,913 32,851
2024-06-30 $1,041,175 13,520